arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

BIO-RAD LABORATORIES, INC.

BIO
$342.64 ▼ -5.49 (-1.58%) at close
Industrials ·Laboratory Analytical Instruments ·USLaboratory Analytical Instruments
19 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Bullish
auto_awesome

Analytical Summary

BIO-RAD LABORATORIES, INC. shows strong fundamentals with top-quartile Profit Margin (%) and Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $9.3B
Dividend Yield
Revenue Growth 0.7%
Op. Margin 1.8%
ROIC 0.4%
FCF / Share $13.74
Trailing P/E 12.3x
Price / Book 1.3x
FCF Yield 4.0%
Debt / Equity 0.16
info Valuation on last close. End-of-day price, Aug 6, 2026.

19-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.58B
↑ +0.7%
Net Income Profit after all expenses
$759.90M
↑ +141.2%
Operating Margin Operating profit as % of sales
1.8%
↓ -82.6% 33th
FCF / Share Free cash flow per share
$13.74
↑ +33.9%
Long-Term Debt Long-term obligations
$1.20B
— +0.2%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
65
Returns
68
Financial Health
65
Cash Quality
39

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 19 years · 71 quarters